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for Analysis of Case-Control Studies: An
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Bhramar Mukherjee and Nilanjan Chatterjee

Abstract

Standard prospective logistic regression analysis of case-control data often leads
to very imprecise estimates of gene-environment interactions due to small numbers of cases or controls in cells of crossing genotype and exposure. In contrast,
under the assumption of gene-environment independence, modern “retrospective”
methods, including the “case-only” approach, can estimate the interaction parameters much more precisely, but they can be seriously biased when the underlying assumption of gene-environment independence is violated. In this article, we
propose a novel approach to analyze case-control data that can relax the geneenvironment independence assumption using an empirical Bayes framework. In
the special case, involving a binary gene and a binary exposure, the framework
leads to an estimator of the odds-ratio interaction parameter in a simple closed
form that corresponds to an weighted average of the standard case-only and casecontrol estimators. We also describe a general approach for deriving the empirical Bayes estimator and its variance within the retrospective maximum-likelihood
framework developed by Chatterjee and Carroll (2005). We conduct simulation
studies to investigate the mean-squared-error of the proposed estimator in both
fixed and random parameter settings. We also illustrate the application of this
methodology using two real data examples. Both simulated and real data examples suggest that the proposed estimator strikes an excellent balance between bias
and efficiency depending on the true nature of the gene-environment association
and the sample size for a given study.
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of crossing genotype and exposure. In contrast, under the assumption of gene-environment independence, modern “retrospective” methods, including the “case-only” approach, can estimate the
interaction parameters much more precisely, but they can be seriously biased when the underlying
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exposure, the framework leads to an estimator of the odds-ratio interaction parameter in a simple
closed form that corresponds to an weighted average of the standard case-only and case-control
estimators. We also describe a general approach for deriving the empirical Bayes estimator and
its variance within the retrospective maximum-likelihood framework developed by Chatterjee and
Carroll (2005). We conduct simulation studies to investigate the mean-squared-error of the proposed estimator in both fixed and random parameter settings. We also illustrate the application of
this methodology using two real data examples. Both simulated and real data examples suggest
that the proposed estimator strikes an excellent balance between bias and efficiency depending on
the true nature of the gene-environment association and the sample size for a given study.
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1 Introduction
While prospective logistic regression remains an established method to analyze case-control data,
recent problems emerging in genetic epidemiology have attracted attention to retrospective analysis
because it can incorporate certain scientifically plausible constraints on the exposure distribution in
the underlying population. In studies of gene-environment association with disease, for example, it
often may be realistic to assume that genetic susceptibilities (G) and environmental exposures (E)
are independent of each other in the underlying population. Piegorsch et al. (1994) noticed that
under G-E independence and assuming a rare disease, the interaction odds-ratio between G and E
can be estimated using the association odds-ratio between these factors in cases alone. Moreover,
this “case-only” estimate of interaction can be much more precise than that obtained from standard
case-control analysis. Umbach and Weinberg (1997) generalized this idea to show that the maximum likelihood estimates of all of the parameters of a logistic regression model involving categorical exposures can be obtained under the independence assumption by fitting a suitably constrained
log-linear model to the case-control data. Recently, Chatterjee and Carroll (2005) developed a rigorous semiparametric framework for retrospective maximum-likelihood analysis of case-control
data under the gene-environment independence assumption in a general setting that may involve
continuous exposures, non-rare diseases and population stratification. The classical result about
the equivalence of prospective and retrospective maximum-likelihood (Andersen, 1970; Prentice
and Pyke, 1979), which assumes unconstrained covariate distribution, does not hold in this setting
and the retrospective approach is generally more efficient (Chatterjee and Carroll, 2005). Similar
gain in efficiency has been also noted for retrospective methods that can incorporate constraints on
the genotype distribution imposed by population genetic laws such as Hardy-Weinberg equilibrium
(Epstein and Satten, 2003; Satten and Epstein 2004; Spinka et al, 2005; Lin and Zeng, 2006).
A major hindrance for practical use of retrospective methods, in spite of their efficiency advantage, has been the potential for large bias in these methods when some of the underlying assumptions such as gene-environment independence or Hardy-Weinberg equilibrium (HWE) are
1
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violated (Albert et al, 2001; Chatterjee and Carroll, 2005; Satten and Epstein 2004; Spinka et al,
2005). A number of alternative strategies for relaxing the underlying assumptions have been proposed. Chatterjee and Carroll (2005) considered a model that can account for gene-environment
dependence due to population stratification. Satten and Epstein (2004) and Lin and Zeng (2006)
considered relaxing the HWE assumption based on alternative more flexible population genetics
models. These models, alleviate the concern of bias somewhat, but may not be adequate because
they only capture certain type of departures from the underlying constraints. One could also use a
two-stage procedure where, at first, one formally tests for the adequacy of the underlying assumption(s) based on the data itself and then use the outcome of that test to decide whether to the use the
efficient retrospective or the more robust prospective method for odds-ratio estimation. For a given
study of modest sample size, however, the power of the tests for HWE or/and gene-environment
independence would be typically low and consequently the two-stage procedure, as a whole, could
still remain significantly biased. Moreover, a proper variance calculation for the two-stage estimator accounting for the underlying model uncertainty can be fairly complicated. The standard
two-stage testing procedure that ignores this model uncertainty maintains a much higher Type-I
error level than desired (Albert et al, 2001).
In this article, we propose a novel solution to the bias vs efficiency dilemma of retrospective
methods using a simple stochastic framework that allows for uncertainty around the assumption of
gene-environment independence. We show how the magnitude of the uncertainty parameter can
be estimated from the data itself. The estimate of this uncertainty parameter is then used, in an
“empirical Bayes (EB)” way, to combine the two sets of estimates of odds-ratio parameters, one
obtained assuming G-E independence and the other obtained allowing a general model for G-E
dependence.
In Section 2, we consider a simple scenario involving a binary G and a binary E, where the
EB estimator of the interaction odds-ratio can be derived in the form of a simple weighted average
of the standard “case-only” and “case-control” estimators. Simulation studies show that in finite

2

Hosted by The Berkeley Electronic Press

samples, the proposed estimator strikes an excellent balance between bias and efficiency depending on the changing scenarios of gene-environment association. Motivated by these results, in
Section 3, we then describe a general approach for deriving such composite estimators for all of
the parameters of a general logistic regression model using the retrospective maximum-likelihood
framework developed by Chatterjee and Carroll (2005). Further simulation studies are conducted
to investigate the performance of the general estimator when there are two environmental exposures, one of which is associated with G and the other is not. In both Sections 2 and 3, a method
for variance estimation for the respective EB estimators is proposed. In Section 4, we analyze two
datasets, both providing compelling evidence of how the EB estimate is tracking the maximum
likelihood estimates from the constrained or unconstrained model depending upon the strength of
G-E association in the respective studies. Section 5 presents discussion and possibilities for future
work.

2 Binary genetic and environmental factors
In this section, we consider the simple set-up of an unmatched case-control study with a binary
genetic factor G and a binary environmental exposure E. Let E = 1 (E = 0) denote an exposed
(unexposed) individual and G = 1 (G = 0) denote whether an individual is a carrier (non-carrier)
of the susceptible genotype. Let D denote disease status, where D = 1 (D = 0) stands for
an affected (unaffected) individual. Let n0 and n1 be the number of selected controls and cases,
respectively. The data can be represented in the form of a 2 × 4 table as displayed in Table 1.
Let r 0 = (r000 , r001 , r010 , r011 ) and r 1 = (r100 , r101 , r110 , r111 ) denote the vector of observed
cell frequencies in the controls and cases respectively. The population parameters, namely, the
cell probabilities corresponding to a particular G-E configuration in the underlying case and
control populations are denoted as p0 = (p000 , p001 , p010 , p011 = 1 − p000 − p001 − p010 ) and
p1 = (p100 , p101 , p110 , p111 = 1 − p100 − p101 − p110 ), respectively. The observed vectors of cell
counts can be viewed as realizations from two independent multinomial distributions, namely, r0 ∼
3
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Multinomial(n0 , p0 ) and r 1 ∼ Multinomial(n1 , p1 ). Let OR10 = p000 p101 /p001 p100 denote the
odds-ratio associated with E for nonsusceptible subjects (G = 0), OR01 = p000 p110 /p010 p100 denote the odds-ratio associated with G for unexposed subjects (E = 0) and OR11 = p000 p111 /p011 p100
denote the odds-ratio associated with G = 1 and E = 1 compared to the baseline category G = 0
and E = 0. Therefore, ψ = OR11 /(OR10 OR01 ) = (p001 p010 p100 p111 ) / (p000 p011 p101 p110 ) is the
multiplicative interaction parameter of interest.
To this end, let us consider a measure of G-E association in the control population, namely,
θGE = log {(p000 p011 )/(p001 p010 )} .

(1)

The assumption of G-E independence, together with the rare disease approximation implies θGE =
0 (Schmidt and Schaid, 1999). When one is not certain about the G-E independence, one may conceptually posit a stochastic framework for the underlying true parameter θGE as, θGE ∼ N(0, τ 2 ),
where τ 2 reflects a measure of uncertainty about the independence assumption. Next we investigate
how one can estimate the prior variability τ 2 using the data itself.
The MLE of the G-E odds-ratio among controls, namely, θGE , is given by
θ̂GE = log {(r000 r011 )/(r001 r010 )} .
Standard likelihood theory implies that, given θGE , θ̂GE ∼ N(θGE , σθ2GE ), where an estimate of the
P P
asymptotic variance is given by σ̂θ2GE = 1g=0 1e=0 (1/r0ge ). Unconditioning on θGE , it follows
that marginally θ̂GE ∼ N(0, τ 2 +σθ2GE ). Thus, based on the marginal likelihood of θ̂GE , a consistent
estimator of the unknown hyperparameter τ 2 can be obtained simply as (Morris, 1983; Greenland,
2
1993), τ̂+2 = max(0, θ̂GE
− σ̂θ2GE ). We propose to use a more conservative estimate of the prior
2
variance obtained as τ̂ 2 = θ̂GE
because it leads to a convenient form for the variance expression of

our subsequently proposed estimator of β = log(ψ).
With this Bayesian framework in mind, we now propose a composite estimator by combining
two commonly used estimators of log(ψ) = β, the one obtained from using case control data
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(β̂CC ), and the other obtained from cases alone (β̂CO ), with the corresponding formulae given by
β̂CC = log

r

001 r010 r100 r111

r000 r011 r101 r110



and

β̂CO = log

r

100 r111

r101 r110



.

Note that β̂CC is the unconstrained MLE of β given the data shown in Table 1, whereas β̂CO
is the MLE under the constraint of G-E independence, i.e. θGE = 0 (Umbach and Weinberg,
1997). Employing standard asymptotic theory, the asymptotic variances of these two estimators
P P P
P P
2
2
can be obtained as σ̂CC
= 1d=0 1g=0 1e=0 (1/rdge ) and σ̂CO
= 1g=0 1e=0 (1/r1ge ). Consider
the following weighted estimator of the interaction parameter:
β̂EB =

2
τ̂ 2
σ̂CC
β̂
+
β̂CC .
CO
2
2
(τ̂ 2 + σ̂CC
)
(τ̂ 2 + σ̂CC
)

(2)

The form of the estimator is motivated by the expression for the posterior mean obtained in a conjugate analysis under a normal-normal model (Berger, 1985, p131), with the prior variance substituted by an estimate obtained from the marginal likelihood in the spirit of Morris (1983). Further
justification of the proposed estimator as a special case of a more general framework is provided
in Section 3. We, however recognize that this estimator is not a true “Bayes” or “empirical Bayes”
estimator in a strict technical sense as we are not carrying out a proper full Bayesian analysis here
with a joint prior structure on all the parameters of interest; we are using prior structure only on
the “nuisance parameter” θGE and embedding that prior uncertainty in the estimation paradigm for
the parameter of interest β. In this sense, the proposed method has a conceptual resemblance to
partially Bayes inference introduced by Cox (1975).
2
We observe that as τ̂ 2 = θ̂GE
→ 0, i.e. as the data provide evidence in favor of G-E in2
dependence in the control population, β̂EB → β̂CO , and as τ̂ 2 = θ̂GE
→ ∞, i.e., as the uncer-

tainty regarding G-E independence in control population becomes stronger, β̂EB → β̂CC . Since
β̂CC = β̂CO − θ̂GE , one can also express the estimator in (2) as
2
β̂EB = β̂CO − K(σ̂CC
, τ̂ )θ̂GE ,
2
2
where the shrinkage factor K(σ̂CC
, τ̂ ) = {1 + (σ̂CC
/τ̂ 2 )}

−1

(3)

“shrinks” θ̂GE , the control log odds-

ratio between G and E, to its hypothesized mean value of zero under the G-E independence
5
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assumption. In the following subsection, we study the performance of the EB estimator under
varying scenarios of G-E association.

2.1 Simulation study for the 2 × 4 table
Although the estimate β̂EB is postulated in a Bayesian framework, it is purely a functional of the
data (namely, the multinomial counts, r 0 and r1 ). The implicit background of assuming a normal
prior with variance τ 2 does not play any explicit role in the computation of this estimator. Thus,
in our simulation, we first study the finite sample properties of this estimator in the standard fixed
parameter setting of a frequentist paradigm. We then proceed to study the performance of this
estimator in a random parameter setting, motivated by a real scenario where one could effectively
elicit a plausible value for the prior hyperparameter τ based on published data.
In the fixed parameter setting, we fix the values for the prevalences of G and E, namely PG and
PE , and the value of the odds-ratio θGE in the control population. Fixing these three quantities,
one is able to obtain the control probability vector p0 by solving a system of equations. We then
set the values of OR10 , OR01 and ψ, which together with p0 , defines the case-probability vector
(Satten and Kupper, 1993). We generate data independently from the two multinomial distributions
corresponding to the case and control populations and compute the case-control, case-only and the
proposed EB estimator under varying scenarios. We also include the two-stage estimator proposed
by Albert et al. (2001) in our simulation study. The two-stage estimator first tests for G-E independence in controls by testing the hypothesis H0 : θGE = 0 at a significance level of α = 0.05, and
based on the acceptance/rejection of this hypothesis, the case-only or the case-control estimator is
then used.
Table 2 presents the mean-squared error (MSE) and bias of different estimators of the interaction parameter β = log(ψ), when PG = PE = 0.3 and OR10 = OR01 = 1. The G-E odds-ratio
among controls, namely, exp(θGE ) is varied at four different values, 1, 1.25, 1.5 and 2. The true
value of β is set at log(2). The results are based on 10000 simulated datasets. The results clearly
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indicate that the proposed EB estimator follows the case-control and the case-only estimators based
on the value of θGE in a data-adaptive way. It has much reduced bias and MSE compared to the
case-only estimator under violation of the independence assumption. It also maintains significantly
smaller MSE compared to the case-control estimator under independence as well as under modest
departures from independence. Under large departures from independence, the EB estimator performs very comparably to the case-control estimator. In contrast, the performance of the case-only
estimator deteriorates sharply as one moves away from the independence assumption. Unlike the
case-only estimator, which is asymptotically biased, any residual bias in the EB estimator goes
to zero in large sample. Under departures from the independence assumption, the EB estimator
also has a clear edge over the two-stage estimator in terms of bias and MSE, especially in small
samples.
In the second set of simulations, we attempt to generate a stochastic model for uncertainty regarding the G-E independence assumption following Marcus et al. (2000), who published data on
association between N-Acetyltranferase 2 (NAT2) acetylation status (slow vs. rapid), and smoking (ever vs. never) using the controls from 11 different case-control studies conducted in US,
Europe, India and Japan (Table 3, Figure 1). Study to study variation in the odds-ratios between
NAT2 and smoking was noted though none of the associations were found to be statistically significant. It is evident that although the overall G-E independence assumption holds (mean over
the 11 sites=0.07), there is variation across study sites (sd=0.35). Treating this as a replica of the
distribution for θGE , in each simulated dataset, we generate θGE at random from a normal distribution with mean 0.07 and standard deviation 0.35, while values of all other simulation parameters
(PG ,PE , OR10 , OR01 and OR11 ) are held fixed.
Results shown in Table 4 bring out certain interesting features of the three estimators. Even
though the overall G-E independence is reasonable, with a variation about the mean, the case-only
estimator becomes inferior, whereas our proposed weighted estimator continues to adapt itself to
model this uncertainty while maintaining significant efficiency gain. In Table 4, we also included a

7
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modification of the EB estimator, namely EB-TRUE, where instead of estimating the prior variance
τ 2 by its marginal MLE, we substituted τ 2 by its true value (0.35)2 . The results illustrate that the
proposed EB estimator is marginally inferior to EB-TRUE, for n0 = n1 = 100, but performs nearly
as well as EB-TRUE for moderately larger sample sizes.
Variance of the proposed estimator: In the following, we propose a method to obtain an asymp2
totic variance expression for β̂EB . Since σ̂CC
→ 0 at the rate of O(1/n), one may ignore the
√
2
variation in σ̂CC
and treat this as a constant while obtaining the first order n-asymptotic approxi-

mation of the EB estimator. Under this setting, the first and second term in (3) could be considered
as asymptotically independent as the first term depends only on cases, and the second depends only
on controls. Using the delta theorem on the second term, considering it as a function of τ̂ = θ̂GE ,
2
and treating σ̂CC
as a constant, we have an estimator of variance of the form,

 θ̂2 (θ̂2 + 3σ̂ 2 ) 2
CC
2
σ̂θ2GE .
VbA (β̂EB ) ≈ σ̂CO
+ GE GE
2
2
2
(σ̂CC + θ̂GE )

(4)

This estimate of the variance in (4), namely, VbA performs remarkably well even in small samples
(n0 = n1 = 100) when compared to the empirical variance (see supplementary Table 1).

3 The general case: profile likelihood and empirical Bayes
Chatterjee and Carroll (2005) have described a general approach for estimation of the parameters of
a logistic regression model from case-control studies under the assumption of gene-environment
independence. They allowed for the presence of stratification factor(s) such as ethnicity which
could be related to both G and E. They consider the following factorization of the retrospective
likelihood,
pr(D|G, E, S)pr(G|E, S)pr(E, S)
.
G,E,s pr(D|G, E, S)pr(G|E, S)pr(E, S)

LR = pr(G, E, S|D) = P

(5)

For continuous exposure E, the sum with respect to E in the denominator of (5) is replaced by
an integral. The ingredients of the retrospective likelihood are constituted in the following way.
Assume a logistic disease incidence model pr(D = 1|G, E, S) = H{γ0 + m(G, E, S; γ1 )}, where
8
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H(u) = (1 + exp(−u))−1 and m(·) is a known but arbitrary function. The joint distribution
function for (E, S) is allowed to remain completely unrestricted (non-parametric). Under G-E
independence, conditional on S, pr(G|E, S) = pr(G|S). Assuming a binary genetic factor G,
consider a logistic model of the form
pr(G = 1|E, S) = H{η0 + η1 S}.

(6)

The model could be extended to a multinomial logistic model for a general categorical G, such
as genotype data for single nucleotide polymorphisms (SNP) which is typically coded as 0, 1 or
2 by counting the number of variant alleles carried by an individual. We will refer to (6) as the
independence model, or the constrained model. Without the assumption of G-E independence,
one can expand the model in (6) to
pr(G = 1|E, S) = H{η0 + η1 S + θE},

(7)

where θ is a measure of dependence between G and E. We will refer to (7) as the dependence or
unconstrained model. Clearly, (6) can be viewed as a special case of (7) with θ = 0.
The maximum-likelihood estimates for the parameters ω = (γ, η) under model (6) as well as
those for ω = (γ, η, θ) under model (7) can be obtained using the profile-likelihood techniques of
Chatterjee and Carroll (2005). In particular, the estimates of the ω- parameters that would maximize the retrospective likelihood LR , while allowing the distribution of Z = (E, S) to remain
completely non-parametric, can be obtained by maximizing a simpler pseudo-likelihood of the
form L∗ = pr(D, G|E, S, R = 1), where the conditioning event R = 1 reflects the outcome dependent sampling mechanism for case-control studies. Computationally, the likelihood L∗ is much
more tractable as it does not require estimation of the high-dimensional “nuisance parameters” involved in specification of the distribution of Z. The details of the estimation method are provided
in Chatterjee and Carroll (2005), and we use their developed software to implement the two models. In the following, the MLE for the common set of regression parameters β=(γ, η) under the
0

unconstrained and constrained models will be denoted by β̂ M L and β̂ M L , respectively.
9
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Before we proceed to form the EB estimator for this particular context, we consider a general
framework where one is interested in estimating a set of focus parameters β in the presence of prior
information on a set of ”nuisance” parameters θ. The general paradigm itself is a novel feature of
this article.
Suppose ζ = (β, θ)T denotes a column-vector of parameters, where β denotes a set of focus
parameters and θ denotes a set of nuisance parameters. Let the dimensions of β and θ be p and m
respectively. Let ζ0 = (β0 , θ0 )T denote the true values of the parameters in the population. Assume
that one is willing to postulate a prior distribution for θ as MVNm (0, A), a m-dimensional zeromean multivariate normal distribution with variance-covariance matrix A. The goal is to conduct
inference on β, without any further prior specification on β. Intuitively, given θ and in the absence
of any prior information on β, a natural way to estimate β would be to use β̂M L (θ), the profile
maximum-likelihood estimate of β for fixed θ. In the following, we show how to utilize the prior
information on θ while working with the profile-MLE β̂(θ). Define β(θ) to be the limiting value
of β̂M L (θ) which is a population parameter with β(θ) = β0 when θ is fixed at the true value θ0 .
0
Note that the constrained MLE for β, with θ = 0, can be written as β̂M
L = β̂M L (θ = 0), and the

unconstrained MLE can be written as β̂M L = β̂M L (θ = θ̂M L ).
Let us then consider the general problem of EB estimation of a general vector function φ =
f (θ), of dimension p when the argument θ (m × 1) has a prior MV Nm (0, A). By applying the
delta theorem, the prior on φ could be approximated as φ ∼ MV Np (f (0), {f ′ (0)}⊤ Af ′ (0)),
where f ′ (θ) = ∂f ⊤ (θ)/∂θ is the gradient matrix of dimension m × p. Let V̂φ be the estimated
asymptotic variance of f (θ̂M L ). Then an approximation to the Bayes estimate of φ = f (θ) for a
fixed A is given by
h
i−1
h
i−1
⊤
⊤
′
′
′
′
f (0).
f (θ̂M L )+V̂φ V̂φ + {f (0)} Af (0)
φ̂ = {f (0)} Af (0) V̂φ + {f (0)} A {f (0)}
′

⊤

′

(8)
By applying (8), the Bayes estimator of β = β(θ) in our setting can be approximated for a known

10
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value of the prior covariance matrix A as,
⊤
−1
⊤
−1
d = ∆⊤ A∆(V̂
β(θ)
β̂M L + ∆ A∆) β(θ̂M L ) + V̂β̂M L (V̂β̂M L + ∆ A∆) β(0),

(9)

where ∆ = ∂β ⊤ (θ)/∂θ, is the gradient matrix of dimension m × p evaluated at θ = 0. Note that
∆⊤ A∆ is a p × p matrix where p is the dimension of β. Now (9) itself cannot be used to estimate
β as it involves the unknown function β(θ). We propose to plug in β̂M L (θ) for β(θ). Further, by
observing the identity S β̂M L (θ) (θ) ≡ 0, where S β (θ) denotes the ML-score function for β given θ,
by chain rule of derivatives, one can derive an estimate of ∆ as
⊤
ˆ = ∂ β̂M L (θ = 0) = −I θβ (θ = 0) {I ββ (0)}−1 .
∆
∂θ

(10)

Here I θβ and I ββ denote suitable information matrices under the unconstrained model. In alignment with the empirical Bayes spirit, we now estimate the prior hyperparameter A by a conserva⊤
tive upper bound to its marginal MLE, given by θ̂M L θ̂M
L . Thus the final form of our proposed EB

estimate is given by


−1
−1
⊤
⊤ ˆ
0
ˆ ⊤ θ̂M L θ̂⊤ ∆
ˆ ⊤ θ̂M L θ̂⊤ ∆
ˆ
ˆ V̂
ˆ
β̂EB = ∆
+
∆
+
∆
β̂
+
V̂
V̂
θ̂
θ̂
∆
β̂M
ML ML
ML
ML
ML
L.
β̂M L
β̂M L
β̂M L
(11)
Computationally, this requires only fitting the constrained model and the unconstrained model and
extracting the variance covariance components for the unconstrained model and evaluating it at
θ = 0.
Revisiting the simple estimator in the 2 × 4 case: Now consider our proposed estimator in the
2 × 4 table. Let the focus parameter β denote the log odds-ratio for interaction and θ denote the
log odds-ratio between G and E in controls. Then, for a fixed θ, β̂M L (θ) ≡ β̂CO − θ where β̂CO
ˆ = ∂ β̂ ⊤ (θ)/∂θ = −1. In this special
denotes the log odds-ratio between G and E in cases. So ∆
ML
case, the prior covariance A is a positive scalar τ 2 , consistent with our previous notation in Section
2. Thus, following (11), the “profile likelihood-empirical Bayes” estimate of β using our general

11

http://biostats.bepress.com/umichbiostat/paper67

framework is given by
β̂EB =
=

σ̂β̂2

ML

(τ̂ 2 + σ̂β̂2

ML

)

0
β̂M
L+

2
σ̂CC
2
2
(θ̂GE
+ σ̂CC
)

β̂CO +

τ̂ 2
(τ̂ 2 + σ̂β̂2

ML

)

β̂M L

2
θ̂GE
2
2
(θ̂GE
+ σ̂CC
)

β̂CC ,

which is exactly what we have proposed in Section 2.
Variance-Covariance matrix of the EB estimate: The variance of the proposed estimator in
0

(9) can be obtained by viewing β̂EB as a function of the ML estimates, (β̂ M L , θ̂M L , β̂ M L ). The
joint asymptotic multivariate normal distribution for these three estimates can be obtained in terms
of the associated score functions and information matrices following classical ML theory. An
application of the multivariate delta theorem provides the variance-covariance expression for β̂EB .
The derivation and expression of the covariance matrix is deferred to the appendix. The small
sample performance of the variance estimator in the simulation setting of Section 3.1 is shown in
supplementary Table 2.

3.1 Simulation study with bivariate environmental exposure
In this section, we design a simulation study involving a binary genetic factor G and two binary
environmental exposures E1 and E2 . The joint distribution of (G, E1 , E2 ) among the controls is
specified as following. We assume P (G = 1) = P (E1 = 1) = P (E2 = 1) = 0.3, and allow
E1 and E2 to be associated with OR(E1 , E2 ) = 2.0. We assume G and E1 are independent with
OR(G, E1 ) = 1, but G and E2 are associated with OR(G, E2) = 1.5. With the parameters fixed
at these values, one can solve a system of equations to obtain the multinomial probability vector
corresponding to the eight possible configurations of (G, E1 , E2 ). We assume a disease risk model
with no main effects for G, E1 or E2 , but allow for interactions for both E1 and E2 with G, with
the corresponding log odds-ratio parameters being βG∗E1 = βG∗E2 = log(2). Given the control
probabilities and the restrictions on the parameters in the disease risk model, one can determine
the probabilities for each (G, E1 , E2 ) configuration in the case population. We also considered
12
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other simulation settings where the disease risk model included main effects (results not shown),
the basic pattern of results remain fairly similar.
The simulation results in Table 5 exhibit that the EB estimator is closer to the constrained MLE
in determining G ∗ E1 interaction, where the independence assumption does in fact hold, whereas
in estimating G ∗ E2 interaction, for which the independence assumption is violated, it is closer
to the unconstrained MLE. For both the interaction parameters, EB has smaller MSE compared
to the unconstrained ML estimator. The constrained ML estimator assuming G-E independence
performs very poorly for estimating G ∗ E2 interaction. If one considers the sum of the MSE’s
corresponding to the two interaction parameters as a performance criterion, the EB estimate has
leverage over all the other contenders.
This simulation brings out a major appealing feature of the “profile-likelihood-empirical-Bayes”
estimator. It is often the case that one is considering multiple interaction parameters where the independence assumption may hold for some, but not hold for others, or may be quite ambiguous for
a subset. In such situations, one can tacitly avoid specifying which of the independence models are
likely to hold and simply use the EB estimator as a data adaptive solution to the vexing problem of
model specification. Remarkably, one can still maintain attractive MSE properties in finite samples
without relying on unverifiable model assumptions.

4 Data analysis
In this section, we apply the proposed methodology to two real datasets, reflecting different degrees of certainty regarding the G-E independence assumption. Both data examples present strong
evidence for the adaptability of the EB estimator depending upon the nature of the G-E association
present in the data.
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4.1 Analysis of Israeli ovarian cancer data
The first example involves a population based case-control study of ovarian cancer conducted
in Israel, data from which was first reported in Modan et al (2001) and was then re-analyzed by
Chatterjee and Carroll (2005). The main goal of the study was to examine how mutations in the two
major susceptibility genes BRCA1 and BRCA2 may interact with known reproductive risk factors
for ovarian cancer, such as number of years of oral contraceptive (OC) use and number of children
(parity). Both Modan et al. (2001) and Chatterjee and Carroll (2005) analyzed data from this study
assuming independence of BRCA1/2 mutations and the reproductive risk factors in the general
population.We re-visited the study to explore how the estimates of regression parameters from the
previous analyses may change if certain amount of uncertainty regarding the gene-environment
independence assumption was allowed using the proposed EB framework.
Our analysis included 1579 observations in the dataset with 832 cases and 747 controls who did
not have bilateral oophorectomy. Similar to Chatterjee and Carroll (2005), we considered fitting a
logistic regression model that included main effects for BRCA1/2 mutations (presence/absence),
OC, parity and the interaction terms OC∗BRCA1/2 and parity∗BRCA1/2. The model was adjusted for a set of covariates S that included age (categorized into 5 groups, by decades), ethnicity
(Ashkenazi or non-Ashkenazi), presence of personal history of breast cancer (PHB), family history
of breast or ovarian cancer (FHBO, coded as 0 for no history in family, 1 for one breast cancer case
in the family and 2 for one ovarian cancer or two or more breast cancers in family) and history of
gynaecological surgery. The model for BRCA1/2 mutation frequency is parameterized as
logit{pr(G = 1|E, S)} = η0 + ηAge I(Age ≥ 50) + ηEth I(Non-Ashkenazi) + ηP H I(PHB = 1)
+ η1F H I(FHBO = 1) + η2F H I(FHBO = 2) + θOC OC + θpar Parity.
Chatterjee and Carroll (2005) assumed the constrained model θOC = θpar = 0, which implies
conditional independence of reproductive risk factors and BRCA1/2 mutation given the stratification factors S. Table 6 shows the estimates and 95% confidence intervals for disease log
14
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odds-ratio parameters of interest under the independence model, dependence model and using
the proposed EB estimator. Under the dependence model, the G-E association parameters were
estimated as θ̂OC = 0.036 and θ̂par =0.094. We can notice from Table 6 that EB inference regarding BRCA1/2∗OC interaction is closer to the independence model, whereas EB inference regarding the BRCA1/2∗parity interaction is intermediate between the unconstrained and constrained
model. This could be expected of the EB estimate as the independence assumption is less certain
for BRCA1/2 and parity based on the current data. The independence model estimator and the EB
estimator produce significant BRCA1/2*OC interaction estimate, while the unconstrained model
fails to detect significance. On the other hand, the BRCA1/2*parity interaction is not significant
under any model, though the confidence intervals based on the constrained MLEs and EB estimator
are noticeably narrower when compared to those obtained from the dependence model.

4.2 Analysis of colorectal adenoma data
The second example involves a case-control study of colorectal adenoma, a precursor of colorectal
cancer, smoking and NAT2, a gene that is believed to play an important role in metabolism of
smoking-related carcinogens. In this study, a total of 772 left-sided prevalent advanced adenoma
cases and 777 gender and ethnicity-matched controls were selected from the screening arm of
the large ongoing Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial at the
National Cancer Institute, USA (Gohagan et al., 2000; Hayes et al., 2005). Subjects selected in the
case-control study were genotyped for six single neucleotide polymorphisms that have been related
to NAT2-acetylation activity in previous laboratory studies. Based on the genotypes, subjects were
assigned an acetylation phenotype as “slow” (NAT 2 = 0), “intermediate” (NAT 2 = 1) or “rapid”
(NAT 2 = 2). Baseline questionnaire data were used to categorize subjects as “never” (SMK =
0), “former” (SMK = 1) or “current” (SMK = 2) smokers. Results from standard logistic
regression analysis of this data has been recently reported by Moslehi et al (2006). We considered
re-analysis of this study in the proposed EB framework. We restricted the analysis to Caucasian
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subjects who has complete NAT2-phenotype information, resulting in a total of 610 cases and 605
controls. We considered fitting a logistic regression model with main effects of smoking , NAT2
(categorized as rapid or not) and their interactions. The model was adjusted for co-factors S that
included age, gender and family history of colorectal cancer (FHCO=1 for yes, 0 for No). The
prevalence of NAT2 rapid acetylation phenotype was modelled as,
logit{P (NAT 2 = 2|E, S)} = η0 + ηF HCO I(F HCO) + ηgender I(Male)
+ θSM K1 I(SMK = 1) + θSM K2 I(SMK = 2).
In this dataset, there seems to be much less certainty about the independence of NAT2 and smoking,
with θSM K1 =0.340; θSM K2 =0.495. Notice that these values can be viewed as typical realizations
from the distribution elicited via the Marcus et al. (2000) data (Figure 1). Estimates of the interaction between NAT2 rapid enzymatic phenotype and current smokers (NAT 2 = 2 ∗ SMK = 2) is
highly significant under all models, whereas the interaction between NAT2 rapid enzymatic phenotypes with former smokers (NAT 2 = 2 ∗ SMK = 1) is not significant under any model. The
EB estimates of interaction parameters for this dataset are not quite close to the ones obtained from
the independence model. The EB confidence intervals are considerably narrower compared to the
corresponding intervals from the dependence model, reflecting the combined efficiency-robustness
feature of the EB estimator.

5 Discussion
Empirical Bayes (Efron and Morris, 1972; Morris, 1983; Efron, 1993; Carlin and Louis, 2000)
is a pragmatic Bayesian paradigm, steering between the extreme Bayesian and frequentist standpoints. In the context of the problem of relaxing gene-environment independence assumption, the
proposed Empirical Bayes (EB) approach has a natural appeal and interpretation, powered with an
extremely straightforward maximum likelihood based computation. This makes the method readily
available and implementable to the practitioner. We believe, for example, the simple closed form
16
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expression for the estimate of interaction between a binary genetic and a binary environmental
exposure should facilitate the use of the method for very large-scale studies such as a genomewide
scan. We also observe that although the estimator is conceived from a Bayesian standpoint, it is
simply a functional of the observed data and can thus be viewed as a novel frequentist estimator.
Our simulation studies involving fixed parameter setting indicate that the estimator has excellent
frequentist properties in the sense of maintaining low mean-squared-errors across different scenarios of gene-environment dependence.
Our simulation study also reveals some interesting features of the case-only estimator. When
we simulated case-control studies from a fixed population (Table 2), for which the gene-environment
independence assumption holds, the case-only estimator of interaction had the smallest meansquared errors among all of the methods considered. However, when we simulated case-control
studies from different populations allowing for some study-to-study variability in the gene-environment
distribution (Table 3), the case-only estimator became much inferior to the case-control estimator
even though the independence assumption was satisfied in the overall super-population. In contrast, the proposed EB estimator always maintained significantly smaller or similar MSE as the
case-control estimator. Given that this kind of study-to-study variability may be expected in practice, as seen in the data published by Marcus et al. (2000), the performance of the EB estimator in
the random parameter setting seems very promising.
As discussed in the introduction, practitioners may find it natural to resolve the bias vs efficiency issue by deciding between the case-only and case-control estimators depending on a statistical test of the independence assumption θGE = 0 using the control sample. This “two-stage”
method essentially leads to an weighted estimator for the interaction parameter with weights being 0-1 random variable indicating the acceptance/rejection of the test of the null hypothesis of
independence. Our simulation studies indicate that the discrete weights of two-stage method generally leads to substantially larger bias and mean-squared-errors than those obtained using the
EB-weights which depend on θGE in a continuous fashion. Moreover, obtaining a proper variance
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estimator for the two-stage estimator, accounting for the uncertainty of the decision rule associated
with the hypothesis testing of independence, can be fairly complex. A naive approach that uses the
standard case-control or case-only variance estimator depending on which of the two estimators is
being used for a given study leads to underestimation of the variance of the whole procedure. The
resulting test of interaction could have highly inflated Type I error (Albert et al., 2001).
Another simple way to combine the case-only and case-control estimator would be to use a
Bayesian Model Averaging (BMA) approach (Madigan and Raftery, 1994) where the weights for
the two estimators could be approximated based on the Bayesian Information Criterions (BIC)
for the constrained and unconstrained retrospective likelihoods. Our simulation studies indicate
(results not included) that the BMA approach has often larger bias and MSE than the EB estimator
because the former method often attaches more weight to the constrained estimator due to the large
penalty given in the BIC criterion for each extra parameter.
The proposed “profile-likelihood-empirical-Bayes” framework has other potential applications
for analysis of case-control studies when certain type of covariate distributional constraints are
likely, but not certain. The same framework, for example, can be used to exploit the constraint of
Hardy-Weinberg equilibrium for genetic association studies. In this context, development of the
EB estimator would first require specifying an “unconstrained” model for the genotype distribution
in which the “constraint” of HWE would be a special case. The maximum-likelihood estimates of
genetic odds-ratio parameters under the constrained and unconstrained models can be then combined based on the estimate(s) of certain index parameter(s) that would measure the magnitude
of departure of the “unconstrained” genotype distribution from HWE. The proposed framework
also raises a number of interesting theoretical issues including how it relates to a proper full Bayes
procedure. Intuitively, a non-informative or minimally informative prior on β, after a possible orthogonalization (Tibshirani, 1989) of the parameter space for (β, θ), may lead to approximately
similar inference. An in-depth, rigorous examination of this connection is needed in the future.
In conclusion, the proposed methodology provides a promising solution to the bias vs efficiency
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dilemma faced in case-control studies due to the assumption of gene-environment independence
assumption. Further, the general framework we provide could be useful for resolving similar issues
in other areas of epidemiologic studies.
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Appendix
Variance approximation for the EB estimate in multivariate setting
0
⊤
We first derive the joint asymptotic distribution of the MLE’s κM L = (β̂M L , θ̂M L , β̂M
L ) obtained

from models (6) and (7). Let I ((p + m) × (p + m)) and I 0 (p × p) denote the observed information
matrices for the unconstrained and the constrained models respectively. Then, asymptotically,


n
√ −1 X
β̂M L
nI
Uβ,θ (Di , Gi, Ei , S i ) + op (n−1/2 )
and,
=
θ̂M L
i=1
0
β̂M
L

=

√

0 −1

n(I )

n
X

Uβ0 (Di , Gi , Ei , S i ) + op (n−1/2 ),

i=1

where Uβ,θ (Di , Gi , S i ), and Uβ0 (Di , Gi , Ei , S i ) denote the individual score functions for subject
i corresponding to the unconstrained and the constrained MLE with n denoting the total sample
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⊤
size. Consider the partitioning I −1 = W ⊤
1 ,W2

⊤

where W 1 is a p × (p + m) matrix and

W 2 is a m × (p + m) matrix. Further, let W 0 = (I 0 )−1 , Ui = Uβ,θ (Di , Gi , S i ) and Ui0 =
Uβ0 (Di , Gi , Ei , S i ). The asymptotic variance- covariance matrix of the vector of MLE’s κM L can
be represented as
ΣκM L =







Pn
W 1 Var( i=1 Ui )W ⊤
1
Pn
⊤
W 2 Var( i=1 Ui )W 1
P
P
W 0 Cov( ni=1 Ui0 , ni=1 Ui )(W 1 )⊤

Pn
W 1 Var( i=1 Ui )W ⊤
2
Pn
⊤
W 2 Var( i=1 Ui )W 2
P
P
W 0 Cov( ni=1 Ui0 , ni=1 Ui )W ⊤
2

Pn
Pn
W 1 Cov( i=1 Ui , i=1 Ui0 )(W 0 )⊤
Pn
Pn
W 2 Cov( i=1 Ui , i=1 Ui0 )(W 0 )⊤
P
W 0 Var( ni=1 Ui0 )(W 0 )⊤





.



Assuming that the first n0 subjects among a total of n selected subjects are controls and remaining
n − n0 subjects are cases, the covariances appearing in the above matrix can be computed under
the case-control sampling scheme as
Cov(

n
X

Xi ,

i=1

n
X

Yi ) = n0

n0
X
i=1

i=1

⊤
Xi Yi⊤ /n0 −X control Y control

n

 X

⊤
⊤
+n1
Xi Yi /n1 −X case Y case .
i=n0 +1

where X case (X control ) and Y case (Y control ) denote the average of X and Y among cases and controls respectively.
Now, we write,


0
β̂EB = g β̂M L , θ̂M L , β̂M
L

−1

−1
⊤
⊤ ˆ
⊤
⊤ ˆ
0
⊤
⊤ ˆ
ˆ
ˆ
ˆ
= ∆ θ̂M L θ̂M L ∆ V̂β̂M L + ∆ θ̂M L θ̂M L ∆
β̂M L + V̂β̂M L V̂β̂M L + ∆ θ̂M L θ̂M L ∆
β̂M
L.

−1
ˆ ⊤ θ̂M L θ̂⊤ ∆
ˆ
V̂
+∆
= β̂M L − V̂
(β̂M L − β̂ 0 ),
(12)
β̂M L

β̂M L

ML

ML

Then, by the multivariate delta theorem, the approximate variance-covariance matrix of β̂EB will
be given by

n 
o⊤


′
0
′
0
g β̂M L , θ̂M L , β̂M L
ΣκM L g β̂M L , θ̂M L , β̂M L ,

0
where g ′ is the gradient matrix of g with respect to (β̂M L , θ̂M L , β̂M
L ). In defining the gradients, we

follow the convention that the derivative of the vector function f (u) (of length r, say) with respect
to a vector u (of length s, say) denotes a matrix of dimension s × r with the (i, j)-th entry given
∂fj
.
by
∂ui
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Lemma: The derivative matrix g ′ ((2p + m) × p) is given by,
g

′



0
β̂M L , θ̂M L , β̂M
L



⊤ ˆ −1 ⊤
ˆ ⊤ θ̂M L θ̂⊤ ∆)
ˆ −1 }, E ⊤ , {V̂
ˆ⊤
= [{I−V̂β̂M L (V̂β̂M L +∆
ML
β̂M L (V̂β̂M L +∆ θ̂M L θ̂M L ∆) }] .

where, E is a m × p matrix,
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0
−1
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ˆ
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)−1 ∆
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β̂M
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⊤
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2
{1 + θ̂M
L ∆(V̂β̂M L ) ∆ θ̂M L }
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−1
Proof: The above expression follows by first noticing that the matrix (V̂β̂M L + ∆⊤ θ̂M L θ̂M
is
L ∆)

of the form (V + uu⊤ )−1 which could be expanded as in (i) below. Further simplification is carried
out by noticing that, for any matrix P and column vectors u and c, of conformable multiplication
orders as needed, the derivative of the vector P uu′c with respect to u can be obtained as in (ii).
(i). (V + uu⊤ )−1 = V −1 −
and, (ii).

(V −1 u)(u⊤ V −1 )
1 + u⊤ V −1 u

∂
P uu⊤ c = u⊤ cP + cu⊤ P .
∂u

The final expression in the lemma is obtained by first using (i), on the expression for β̂EB as in
(12), followed by using the quotient rule of differentiation. The result in (ii) is used to differenti⊤
ate terms of the form P ∆⊤ θ̂M L θ̂M
L ∆c with respect to θ̂M L which appear in the numerator of the

quotient. Some algebraic manipulation leads to the expression for E.
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Table 1: Data for a unmatched case-control study with a binary genetic factor and a binary environmental exposure
G=0
G=1
E=0 E=1
E = 0 E = 1 total
D=0
r000
r001
r010
r011
n0
D=1
r100
r101
r110
r111
n1

Table 2: Simulation results showing mean squared error and bias (in parentheses) in estimation
of the interaction parameter β = log(ψ) for different methods under varying scenarios of G-E
association. The value of θGE is the control odds ratio between G and E. The prevalences of G
and E were fixed at PG = PE = 0.3 in the control population. The parameters in the disease risk
model were set at OR10 = OR01 = 1 and β = log(ψ) = log(2) = 0.6931.

case-control
θGE = 0
case-only
EB
two-stage
case-control
θGE =log(1.25)
case-only
EB
two-stage
case-control
θGE = log(1.5)
case-only
EB
two-stage
case-control
θGE = log(2)
case-only
EB
two-stage

Sample Size
n0 = n1 = 100 n0 = n1 = 200 n0 = n1 = 500
0.46 (0.03)
0.22(0.02)
0.08(0.00)
0.20(0.01)
0.10(0.01)
0.04(0.00)
0.29(0.02)
0.14(0.01)
0.05(0.00)
0.26 (0.00)
0.13(0.01)
0.05 (0.00)
0.45 (0.02)
0.21(0.00)
0.08(0.01)
0.26 (0.24)
0.15 (0.23)
0.09 (0.23)
0.31 (0.12)
0.16 (0.10)
0.07 (0.09)
0.31 (0.16)
0.19 (0.15)
0.10 (0.13)
0.45 (0.02)
0.21 (0.01)
0.08 (0.00)
0.39 (0.43)
0.27 (0.42)
0.21 (0.41)
0.37(0.19)
0.20(0.16)
0.10(0.12)
0.44 (0.27)
0.28 (0.22)
0.15 (0.13)
0.45 (0.03)
0.21 (0.02)
0.08 (0.01)
0.74 (0.73)
0.60 (0.71)
0.54 (0.70)
0.46 (0.27)
0.26(0.20)
0.11 (0.12)
0.67 (0.34)
0.38 (0.19)
0.11 (0.03)
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Table 3: Odds-ratios of association between NAT2 acetylation activity (rapid vs slow) and smoking
(ever vs. never) estimated using controls from 11 different case-control studies (Marcus et al.,
2000)
Study site

ORGE

θGE = log(ORGE )

Brockmoller
Taylor
Risch
Mommsen
Roots
Kaisary
Romkes
Dewan
Ishizu
Karakaya

1.16
1.44
1.85
0.88
0.56
0.76
0.95
1.04
1.23
1.39

0.15
0.37
0.62
-0.13
-0.57
-0.28
-0.06
0.03
0.21
0.33

P -value
for testing
H0 : θGE = 0
0.55
0.21
0.39
0.81
0.29
0.48
0.92
0.94
0.73
0.42

Table 4: Simulation results showing mean-squared-error and bias (in parentheses) in estimation of
the interaction parameter β = log(ψ) when the control odds-ratio between G and E, namely, θGE
is randomly generated from a N(0.07,0.35) distribution for each simulated dataset, reflecting the
distribution elicited from Marcus et al., 2000 meta analysis. The prevalences of G and E are fixed
at PG = PE = 0.3. The parameters in the disease risk model are fixed at OR10 = OR01 = 1 and
β = log(ψ) = log(2) = 0.6931.
Sample Size
n0 = n1 = 100 n0 = n1 = 200 n0 = n1 = 500
case-control
0.45 (0.03)
0.22 (0.01)
0.08 (0.00)
case-only
0.33 (0.08)
0.23 (0.07)
0.17 (0.06)
EB
0.33 (0.05)
0.18 (0.03)
0.08 (0.02)
1
EB-TRUE (τ = 0.35)
0.30 (0.06)
0.17 (0.04)
0.08 (0.03)
1:

This is the Bayes estimate obtained by using the true simulation value of the prior parameter τ instead of
estimating τ from the marginal likelihood.
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Table 5: Simulation results showing mean-squared error and bias (in parentheses) for estimation of
interaction parameters of one genetic factor (G) with two environmental exposures (E1 , E2 ). The
joint distribution of (G, E1 , E2 ) in the controls was specified by the following restrictions: P (E1 =
1) = P (E2 = 1) = P (G = 1) = 0.3, ORE1 E2 = 2.0, ORGE1 = 1, ORGE2 = 1.5. The parameters
for the disease risk model were set at βG = βE1 = βE2 = 0, and, βG∗E1 = βG∗E2 = log(2).
MSE1
MSE2
MSE1
(G ∗ E1 )
(G ∗ E2 ) +MSE2
Dependence
0.46 (0.04) 0.48 (0.10)
0.94
n0 = n1 = 100
Independence
0.20 (0.04) 0.39 (0.44)
0.59
Empirical Bayes 0.29 (0.03) 0.36 (0.24)
0.65
Dependence
0.21 (0.05) 0.21 (0.01)
0.42
n0 = n1 = 200
Independence
0.10 (0.02) 0.26 (0.41)
0.36
Empirical Bayes 0.15 (0.03) 0.16 (0.14)
0.31
Dependence
0.08 (0.01) 0.09 (0.01)
0.17
n0 = n1 = 500
Independence
0.04 (0.00) 0.21 (0.41)
0.25
Empirical Bayes 0.06 (0.00) 0.09 (0.12)
0.15
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Table 6: Analysis of Israeli ovarian cancer data: Estimates of the log odds-ratio parameters corresponding to each effect is provided,
accompanied with 95% confidence intervals.1
β̂BRCA1/2
β̂OC
β̂parity
β̂BRCA1/2∗OC β̂BRCA1/2∗parity
Dependence
3.442
-0.051
-0.060
0.049
-0.131
CI
(2.476,4.408) (-0.108,0.006) (-0.126,0.006) (-0.104,0.203) (-0.373,0.111)
Independence
3.154
-0.051
-0.061
0.086
-0.036
CI
(2.509,3.799) (-0.102,-0.001) (-0.125,0.002) (0.021,0.15)
(-0.141,0.068)
Empirical Bayes
3.270
-0.051
-0.062
0.070
-0.077
CI
(2.620, 3.921) (-0.108,0.006) (-0.127,0.005) (0.002,0.139) (-0.185,0.032)
1
The analysis is adjusted for effects of age, ethnicity, personal history of breast cancer, family history of breast or ovarian cancer and
history of gynaecological surgery.
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Table 7: Analysis of colorectal adenoma data: Estimates of the log odds-ratio parameters corresponding to each effect is provided,
accompanied with 95% confidence intervals.2
β̂N AT 2=2
β̂SM K=1
β̂SM K=2
β̂N AT 2=2∗SM K=1
Dependence
0.833
0.196
1.03
-1.103
CI
(0.035,1.632) (-0.073,0.464) (0.692,1.367) (-2.227,0.021)
Independence
0.596
0.176
0.999
-0.766
CI
(-0.046,1.239) (-0.089,0.443) (0.667,1.332) (-1.630,0.098)
Empirical Bayes
0.698
0.183
1.009
-0.923
CI
(-0.031,1.426) (-0.083, 0.449) (0.678,1.339) (-1.956, 0.111)
2
The analysis is adjusted for effects of age, gender and family history of colorectal cancer.

β̂N AT 2=2∗SM K=2
-2.784
(-4.569,-0.998)
-2.308
(-3.885,-0.732)
-2.531
(-4.214,-0.848)
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Figure 1: Histogram of log odds-ratios between NAT2 and smoking in control subjects from 11
case-control studies conducted in several study sites across US, Europe, Japan and India (Marcus
et al., 2000).
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